400-920-2911 sales@csnpharm.cn
CAS No.: 863680-45-9
GSK598809 is a selective D(3)R antagonist recently progressed in Phase I trials. GSK-598809 may decrease the rewarding effects of contextual cues associated with drug intake preclinically, which may reduce drug craving in humans.
规格 | 价格 | 促销价格 | 库存 | 数量 |
---|
生物活性
NCT号 | 适应症或疾病 | 临床期 | 招募状态 | 预计完成时间 | 地点 |
---|---|---|---|---|---|
NCT00513279 | Substance Dependence | Phase 1 | Completed | - | United Kingdom ... more >> GSK Investigational Site Harrow, Middlesex, United Kingdom, HA13UJ Collapse << |
NCT00793468 | Substance Dependence | Phase 2 | Withdrawn(Study halted prior t... more >>o enrollment of patients) Collapse << | December 2008 | United States, Florida ... more >> GSK Investigational Site Deland, Florida, United States, 32720 GSK Investigational Site Pembroke Pines, Florida, United States, 33024 United States, Georgia GSK Investigational Site Stockbridge, Georgia, United States, 30281 United States, Kansas GSK Investigational Site Overland Park, Kansas, United States, 66211 United States, Nevada GSK Investigational Site Las Vegas, Nevada, United States, 89104 United States, New York GSK Investigational Site Rochester, New York, United States, 14609 United States, North Carolina GSK Investigational Site Raleigh, North Carolina, United States, 27612 United States, Oregon GSK Investigational Site Portland, Oregon, United States, 97239 United States, Pennsylvania GSK Investigational Site Philadelphia, Pennsylvania, United States, 19104 United States, Texas GSK Investigational Site Dallas, Texas, United States, 75234 Collapse << |
NCT01039454 | Substance Dependence | Phase 1 | Completed | - | United Kingdom ... more >> GSK Investigational Site Cambridge, Cambridgeshire, United Kingdom, CB2 0QQ GSK Investigational Site London, United Kingdom, NW10 7EW Collapse << |
实验方案
技术信息
CAS号 | 863680-45-9 | 储存条件 |
|
|
分子式 | C22H23F4N5OS | 运输 | 蓝冰 | |
分子量 | 481.51 | 别名 |